Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting.

Paolo MannelliAntoine B DouaihySarah C AkermanAnna LegedzaJames FratantonioAbigail ZavodMaria A Sullivan

Published in: The American journal on addictions (2022)

These findings may assist clinicians in optimizing outcomes of the BUP to XR-NTX transition and supporting patients to make better informed MOUD decisions.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
mental health
prognostic factors
patient reported outcomes
combination therapy
decision making
insulin resistance
smoking cessation
replacement therapy